REZI insider files Form 144 to sell 47,500 shares on NYSE via Morgan Stanley

Rhea-AI Filing Summary

Resideo Technologies (REZI) filed a Form 144 disclosing a proposed sale of 47,500 shares of common stock, with an aggregate market value of $1,486,279.75, to be sold on the NYSE through Morgan Stanley Smith Barney LLC with an approximate sale date of 08/12/2025. The filing shows total shares outstanding of 148,763,403, and states there were no securities sold in the past three months by the selling person.

The securities offered were received as restricted stock in three lots dated 02/18/2023 (19,446 shares), 02/18/2024 (2,592 shares) and 02/09/2025 (25,462 shares). The filer affirms they are not aware of any undisclosed material adverse information about the issuer.

Positive

• Public disclosure of the proposed sale of 47,500 shares providing market transparency
• No recorded sales by the reporting person in the prior three months, as stated in the filing

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine insider notice for a planned sale of 47,500 REZI shares; disclosure is transparent and appears non-disruptive.

The Form 144 reports a proposed sale of 47,500 common shares valued at $1,486,279.75 on the NYSE via Morgan Stanley Smith Barney LLC. The filing provides acquisition dates and shows the shares were issued as restricted stock in three separate lots. There are no reported sales by the person in the prior three months, which reduces immediate questions about systematic disposition. Based solely on the quantities disclosed here, the notice is informational rather than a sign of material corporate change.

Corporate Governance Expert

TL;DR: Proper procedural disclosure under Rule 144; the filing documents restricted stock holdings being cleared for sale.

The filer documents the nature of acquisition as restricted stock and includes required representations about material nonpublic information. The record of three acquisition dates and the absence of sales in the past three months are consistent with compliance-focused reporting. From a governance standpoint this is a standard insider disposition notice without disclosed allegations, litigation, or other governance red flags in the filing content.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	47500	1486279.75	148763403	08/12/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/18/2024	Restricted Stock	Issuer			2592	02/18/2024	Not Applicable
Common	02/18/2023	Restricted Stock	Issuer			19446	02/18/2023	Not Applicable
Common	02/09/2025	Restricted Stock	Issuer			25462	02/09/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the REZI Form 144 disclose?

The filing discloses a proposed sale of 47,500 common shares of Resideo (REZI) with an aggregate market value of $1,486,279.75 and an approximate sale date of 08/12/2025.

Through which broker will the REZI shares be sold?

The filing lists Morgan Stanley Smith Barney LLC as the broker handling the proposed sale.

Were the shares acquired or purchased, and when?

The shares were received as restricted stock in three lots on 02/18/2023 (19,446 shares), 02/18/2024 (2,592 shares), and 02/09/2025 (25,462 shares).

Has the filer sold REZI securities in the past three months?

The filing states Nothing to Report for securities sold during the past three months by the person for whose account the securities are to be sold.

How many REZI shares are outstanding per the filing?

The filing reports 148,763,403 shares outstanding for the issuer.